UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 400

Sortiert nach

Mechanisms of action of tasquinimod on the tumour microenvironment

Cancer chemotherapy and pharmacology, 2014-01, Vol.73 (1), p.1-8

2014

Volltextzugriff (PDF)

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2013-12, Vol.19 (24), p.6891-6901

2013

Volltextzugriff (PDF)

FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist

Scandinavian journal of urology, 2018-11, Vol.52 (5-6), p.349-357

2018

Volltextzugriff (PDF)

A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer

Cancer epidemiology, 2010-10, Vol.34 (5), p.574-579

2010

Volltextzugriff (PDF)

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

British journal of cancer, 2009-10, Vol.101 (8), p.1233-1240

2009

Volltextzugriff (PDF)

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

Prostate cancer and prostatic diseases, 2009, Vol.12 (2), p.160-165

2009

Volltextzugriff (PDF)

Segregation Analysis of Prostate Cancer in Sweden: Support for Dominant Inheritance

American journal of epidemiology, 1997-10, Vol.146 (7), p.552-557

1997

Volltextzugriff (PDF)

Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival

International journal of oncology, 2000-09, Vol.17 (3), p.445

2000

Volltextzugriff (PDF)

COMBINED ORCHIECTOMY AND EXTERNAL RADIOTHERAPY VERSUS RADIOTHERAPY ALONE FOR NONMETASTATIC PROSTATE CANCER WITH OR WITHOUT PELVIC LYMPH NODE INVOLVEMENT: A PROSPECTIVE RANDOMIZED STUDY

The Journal of urology, 1998-06, Vol.159 (6), p.2030-2034

1998

Volltextzugriff (PDF)

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

Urology (Ridgewood, N.J.), 2003, Vol.61 (1), p.145-151

2003

Volltextzugriff (PDF)

Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search

Science (American Association for the Advancement of Science), 1996-11, Vol.274 (5291), p.1371-1374

1996

Volltextzugriff (PDF)

Decreasing mortality rates for prostate cancer: possible role of hormonal therapy?

BJU international, 2004-04, Vol.93 (6), p.695-701

Damber, J.‐E.

2004

Volltextzugriff (PDF)

The expression of thrombospondin‐1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer

BJU international, 2004-06, Vol.93 (9), p.1339-1343

2004

Volltextzugriff (PDF)

Hereditary Prostate Cancer: Clinical Characteristics and Survival

The Journal of urology, 2002-06, Vol.167 (6), p.2423-2426

2002

Volltextzugriff (PDF)

Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts

Prostate cancer and prostatic diseases, 2009-03, Vol.12 (1), p.41-46

2009

Volltextzugriff (PDF)

Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice

The Prostate, 2000-03, Vol.42 (4), p.304-314

2000

Volltextzugriff (PDF)

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer

European journal of cancer (1990), 2000-01, Vol.36 (2), p.235-241

2000

Volltextzugriff (PDF)

Familial prostate cancer in sweden: A nationwide register cohort study

Cancer, 1996-01, Vol.77 (1), p.138-143

1996

Volltextzugriff (PDF)

Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

The Prostate, 1997-09, Vol.33 (1), p.38-45

1997

Volltextzugriff (PDF)

Phytoestrogens and Prostate Disease

The Journal of nutrition, 2000-03, Vol.130 (3), p.658S-659S

2000

Volltextzugriff (PDF)

Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats

The Prostate, 1998-08, Vol.36 (3), p.151-161

1998

Volltextzugriff (PDF)

Total Food Consumption and Body Mass Index in Relation to Prostate Cancer Risk: A Case-Control Study in Sweden with Prospectively Collected Exposure Data

The Journal of urology, 1996-03, Vol.155 (3), p.969-974

1996

Volltextzugriff (PDF)

TESTOSTERONE INDUCES VASCULAR ENDOTHELIAL GROWTH FACTOR SYNTHESIS IN THE VENTRAL PROSTATE IN CASTRATED RATS

The Journal of urology, 1999-05, Vol.161 (5), p.1620-1625

1999

Volltextzugriff (PDF)

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

The New England journal of medicine, 2017-07, Vol.377 (4), p.352-360

2017

Volltextzugriff (PDF)

The clinical implications of the difference between castration, gonadotrophin releasing‐hormone (GnRH) antagonists and agonist treatment on the morphology and expression of GnRH receptors in the rat ventral prostate

BJU international, 2003-02, Vol.91 (3), p.227-233

2003

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(318)
Mit Volltextzugriff
(315)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of action of tasquinimod on the tumour microenvironment

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist

A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

Segregation Analysis of Prostate Cancer in Sweden: Support for Dominant Inheritance

Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival

COMBINED ORCHIECTOMY AND EXTERNAL RADIOTHERAPY VERSUS RADIOTHERAPY ALONE FOR NONMETASTATIC PROSTATE CANCER WITH OR WITHOUT PELVIC LYMPH NODE INVOLVEMENT: A PROSPECTIVE RANDOMIZED STUDY

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search

Decreasing mortality rates for prostate cancer: possible role of hormonal therapy?

The expression of thrombospondin‐1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer

Hereditary Prostate Cancer: Clinical Characteristics and Survival

Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts

Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer

Familial prostate cancer in sweden: A nationwide register cohort study

Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

Phytoestrogens and Prostate Disease

Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats

Total Food Consumption and Body Mass Index in Relation to Prostate Cancer Risk: A Case-Control Study in Sweden with Prospectively Collected Exposure Data

TESTOSTERONE INDUCES VASCULAR ENDOTHELIAL GROWTH FACTOR SYNTHESIS IN THE VENTRAL PROSTATE IN CASTRATED RATS

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

The clinical implications of the difference between castration, gonadotrophin releasing‐hormone (GnRH) antagonists and agonist treatment on the morphology and expression of GnRH receptors in the rat ventral prostate

Suchergebnisse filtern